Detection of solitary and primary-multiple tumors in the female reproductive system

The method of early diagnosis of solitary and primary multiple hormone-dependent neoplasms in the reproductive system organs based on two-stage screening of healthy women, consisting in obtaining an optimized diagnostic system, allowing high frequency (59-68% with the number of the surveyed group - 5-8.5% of population numbers) to identify prematubic and tumor diseases of the organs of the female reproductive system on a preclinical stage based on pathogenetic risk factors. At the same time, on the basis of a multifactoric analysis of the characteristics of the body (the age, state of the reproductive system, the severity of endocrine-metabolic disorders) establishes the magnitude of the individual relative risks of the development of solitary and primary multiple tumors among a healthy population and patients with hormone-dependent cancer.
The technology is intended for oncologists, gynecologists, surgeons, health organizers and all specialists working in the field of prevention and early diagnosis of malignant neoplasms, and can be used both specialized and multidisciplinary medical institutions